位置:首页 > 蛋白库 > SPRTN_XENLA
SPRTN_XENLA
ID   SPRTN_XENLA             Reviewed;         565 AA.
AC   A0A1L8G2K9; A1L3F9; B1H1N6;
DT   02-DEC-2020, integrated into UniProtKB/Swiss-Prot.
DT   15-MAR-2017, sequence version 1.
DT   03-AUG-2022, entry version 25.
DE   RecName: Full=DNA-dependent metalloprotease SPRTN {ECO:0000305};
DE            EC=3.4.24.- {ECO:0000305|PubMed:30595436};
DE   AltName: Full=Protein with SprT-like domain at the N terminus {ECO:0000250|UniProtKB:Q9H040};
DE            Short=Spartan {ECO:0000250|UniProtKB:Q9H040};
GN   Name=sprtn {ECO:0000303|PubMed:30595436};
GN   ORFNames=XELAEV_18029135mg {ECO:0000312|EMBL:OCT78037.1};
OS   Xenopus laevis (African clawed frog).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia;
OC   Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus; Xenopus.
OX   NCBI_TaxID=8355;
RN   [1] {ECO:0000312|Proteomes:UP000186698}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=J;
RX   PubMed=27762356; DOI=10.1038/nature19840;
RA   Session A.M., Uno Y., Kwon T., Chapman J.A., Toyoda A., Takahashi S.,
RA   Fukui A., Hikosaka A., Suzuki A., Kondo M., van Heeringen S.J., Quigley I.,
RA   Heinz S., Ogino H., Ochi H., Hellsten U., Lyons J.B., Simakov O.,
RA   Putnam N., Stites J., Kuroki Y., Tanaka T., Michiue T., Watanabe M.,
RA   Bogdanovic O., Lister R., Georgiou G., Paranjpe S.S., van Kruijsbergen I.,
RA   Shu S., Carlson J., Kinoshita T., Ohta Y., Mawaribuchi S., Jenkins J.,
RA   Grimwood J., Schmutz J., Mitros T., Mozaffari S.V., Suzuki Y., Haramoto Y.,
RA   Yamamoto T.S., Takagi C., Heald R., Miller K., Haudenschild C., Kitzman J.,
RA   Nakayama T., Izutsu Y., Robert J., Fortriede J., Burns K., Lotay V.,
RA   Karimi K., Yasuoka Y., Dichmann D.S., Flajnik M.F., Houston D.W.,
RA   Shendure J., DuPasquier L., Vize P.D., Zorn A.M., Ito M., Marcotte E.M.,
RA   Wallingford J.B., Ito Y., Asashima M., Ueno N., Matsuda Y., Veenstra G.J.,
RA   Fujiyama A., Harland R.M., Taira M., Rokhsar D.S.;
RT   "Genome evolution in the allotetraploid frog Xenopus laevis.";
RL   Nature 538:336-343(2016).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary;
RG   NIH - Xenopus Gene Collection (XGC) project;
RL   Submitted (MAR-2008) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, ACTIVE SITE, AND
RP   MUTAGENESIS OF GLU-89; 231-PHE--LEU-238; 331-GLN--PHE-338; 439-CYS--CYS-442
RP   AND 540-CYS--CYS-543.
RX   PubMed=30595436; DOI=10.1016/j.molcel.2018.11.024;
RA   Larsen N.B., Gao A.O., Sparks J.L., Gallina I., Wu R.A., Mann M.,
RA   Raeschle M., Walter J.C., Duxin J.P.;
RT   "Replication-coupled DNA-protein crosslink repair by SPRTN and the
RT   proteasome in Xenopus egg extracts.";
RL   Mol. Cell 73:574-588(2019).
CC   -!- FUNCTION: DNA-dependent metalloendopeptidase that mediates the
CC       proteolytic cleavage of covalent DNA-protein cross-links (DPCs) during
CC       DNA synthesis, thereby playing a key role in maintaining genomic
CC       integrity (PubMed:30595436). DPCs are highly toxic DNA lesions that
CC       interfere with essential chromatin transactions, such as replication
CC       and transcription, and which are induced by reactive agents, such as UV
CC       light or formaldehyde (By similarity). Associates with the DNA
CC       replication machinery and specifically removes DPCs during DNA
CC       synthesis (By similarity). Acts as a pleiotropic protease for DNA-
CC       binding proteins cross-linked with DNA, such as top1, top2a, histones
CC       H3 and H4 (By similarity). Mediates degradation of DPCs that are not
CC       ubiquitinated, while it is not able to degrade ubiquitinated DPCs
CC       (PubMed:30595436). SPRTN activation requires polymerase collision with
CC       DPCs followed by helicase bypass of DPCs (PubMed:30595436). May also
CC       act as a 'reader' of ubiquitinated pcna: facilitates chromatin
CC       association of rad18 and is required for efficient pcna
CC       monoubiquitination, promoting a feed-forward loop to enhance pcna
CC       ubiquitination and translesion DNA synthesis (By similarity). Acts as a
CC       regulator of translesion DNA synthesis by recruiting vcp/p97 to sites
CC       of DNA damage (By similarity). {ECO:0000250|UniProtKB:Q9H040,
CC       ECO:0000269|PubMed:30595436}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000250|UniProtKB:Q9H040};
CC   -!- ACTIVITY REGULATION: DNA-binding activates the protease activity:
CC       single-stranded DNA-binding specifically activates ability to cleave
CC       covalent DNA-protein cross-links (DPCs) (By similarity). In contrast,
CC       double-stranded DNA-binding specifically activates autocatalytic
CC       cleavage, and subsequent inactivation (By similarity).
CC       {ECO:0000250|UniProtKB:Q9H040}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250|UniProtKB:Q9H040}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9H040}.
CC       Chromosome {ECO:0000269|PubMed:30595436}. Note=Localizes to sites of UV
CC       damage via the PIP-box (By similarity). Recruited to stalled
CC       replication forks at sites of replication stress (By similarity).
CC       {ECO:0000250|UniProtKB:Q9H040}.
CC   -!- DOMAIN: The UBZ4-type zinc fingers mediate binding to 'Lys-48'- and
CC       'Lys-63'-linked polyubiquitin. {ECO:0000250|UniProtKB:Q9H040}.
CC   -!- PTM: Autocatalytically cleaved in response to double-stranded DNA-
CC       binding: autocatalytic cleavage takes place in trans and leads to
CC       inactivation. {ECO:0000250|UniProtKB:Q9H040}.
CC   -!- SIMILARITY: Belongs to the Spartan family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI30076.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAI60677.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CM004475; OCT78037.1; -; Genomic_DNA.
DR   EMBL; BC160677; AAI60677.1; ALT_INIT; mRNA.
DR   EMBL; BC130075; AAI30076.1; ALT_INIT; mRNA.
DR   RefSeq; XP_018120824.1; XM_018265335.1.
DR   AlphaFoldDB; A0A1L8G2K9; -.
DR   SMR; A0A1L8G2K9; -.
DR   GeneID; 100036995; -.
DR   KEGG; xla:100036995; -.
DR   CTD; 100036995; -.
DR   Xenbase; XB-GENE-5845827; sprtn.S.
DR   OMA; DPTWELL; -.
DR   OrthoDB; 1171375at2759; -.
DR   Proteomes; UP000186698; Chromosome 5S.
DR   Bgee; 100036995; Expressed in egg cell and 19 other tissues.
DR   GO; GO:0000785; C:chromatin; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0003690; F:double-stranded DNA binding; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004222; F:metalloendopeptidase activity; ISS:UniProtKB.
DR   GO; GO:0003697; F:single-stranded DNA binding; ISS:UniProtKB.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; ISS:UniProtKB.
DR   GO; GO:0016540; P:protein autoprocessing; ISS:UniProtKB.
DR   GO; GO:0106300; P:protein-DNA covalent cross-linking repair; IMP:UniProtKB.
DR   GO; GO:0006508; P:proteolysis; ISS:UniProtKB.
DR   InterPro; IPR006642; Rad18_UBZ4.
DR   InterPro; IPR044245; Spartan.
DR   InterPro; IPR006640; SprT-like_domain.
DR   PANTHER; PTHR21220; PTHR21220; 1.
DR   Pfam; PF10263; SprT-like; 1.
DR   SMART; SM00731; SprT; 1.
DR   SMART; SM00734; ZnF_Rad18; 2.
DR   PROSITE; PS51908; ZF_UBZ4; 2.
DR   PROSITE; PS00142; ZINC_PROTEASE; 1.
PE   1: Evidence at protein level;
KW   Autocatalytic cleavage; Chromosome; DNA damage; DNA repair; Hydrolase;
KW   Isopeptide bond; Metal-binding; Metalloprotease; Nucleus; Protease;
KW   Reference proteome; Repeat; Zinc; Zinc-finger.
FT   CHAIN           1..565
FT                   /note="DNA-dependent metalloprotease SPRTN"
FT                   /id="PRO_0000451418"
FT   DOMAIN          23..130
FT                   /note="SprT-like"
FT                   /evidence="ECO:0000255"
FT   ZN_FING         436..463
FT                   /note="UBZ4-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01256"
FT   ZN_FING         537..564
FT                   /note="UBZ4-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01256"
FT   REGION          191..219
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          349..389
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           231..239
FT                   /note="SHP-box"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H040"
FT   MOTIF           288..295
FT                   /note="PIP-box"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H040"
FT   MOTIF           476..499
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H040"
FT   COMPBIAS        192..206
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        89
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10095,
FT                   ECO:0000305|PubMed:30595436"
FT   BINDING         88
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H040,
FT                   ECO:0000255|PROSITE-ProRule:PRU10095"
FT   BINDING         92
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H040,
FT                   ECO:0000255|PROSITE-ProRule:PRU10095"
FT   BINDING         107
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H040"
FT   BINDING         439
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01256"
FT   BINDING         442
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01256"
FT   BINDING         454
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01256"
FT   BINDING         458
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01256"
FT   BINDING         540
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01256"
FT   BINDING         543
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01256"
FT   BINDING         555
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01256"
FT   BINDING         559
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01256"
FT   MUTAGEN         89
FT                   /note="E->Q: Abolished metalloprotease activity and ability
FT                   to cleave covalent DNA-protein cross-links (DPCs)."
FT                   /evidence="ECO:0000269|PubMed:30595436"
FT   MUTAGEN         231..238
FT                   /note="FSGTGYKL->ASGTGYKA: Does not affect metalloprotease
FT                   activity and ability to cleave covalent DNA-protein cross-
FT                   links (DPCs)."
FT                   /evidence="ECO:0000269|PubMed:30595436"
FT   MUTAGEN         331..338
FT                   /note="QKSVLPFF->AKSALPAA: Does not affect metalloprotease
FT                   activity and ability to cleave covalent DNA-protein cross-
FT                   links (DPCs)."
FT                   /evidence="ECO:0000269|PubMed:30595436"
FT   MUTAGEN         439..442
FT                   /note="CPVC->APVA: Abolished metalloprotease activity and
FT                   ability to cleave covalent DNA-protein cross-links (DPCs);
FT                   when associated with 540-A--A-543."
FT                   /evidence="ECO:0000269|PubMed:30595436"
FT   MUTAGEN         540..543
FT                   /note="CPVC->APVA: Abolished metalloprotease activity and
FT                   ability to cleave covalent DNA-protein cross-links (DPCs);
FT                   when associated with 439-A--A-442."
FT                   /evidence="ECO:0000269|PubMed:30595436"
FT   CONFLICT        204
FT                   /note="D -> Y (in Ref. 2; AAI60677/AAI30076)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        270
FT                   /note="P -> L (in Ref. 2; AAI60677/AAI30076)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   565 AA;  62607 MW;  1E3E6E710CD7DBB9 CRC64;
     MGDMQMSVVD PTWELLDPNP DIRALFLEFN DTFFWGQLSG VEVKWSARMT LCAGVCSYEG
     RGGLCSIRLS EPLLKLRPRK DLVETLLHEM IHALLFVTHN NKDHDSHGPE FCKHMERING
     RTGANISVYH NFHDEVDEYR KHWWLCNGPC QKRKPYFGYV KRAMNRAPSS LDPWWADHQR
     TCGGSFVKVK EPENYPQKRK RKNDPTISEV NSSSHVKGKS NGVDIRTVIP FSGTGYKLFE
     PNKSDAPLKI LNINPTKDKA AVPLLNHTPP STNINGTFLT NKIGSAKSTP AQSILTKVSV
     ANTKVFINLN GSPIKLPSGS KNKSHQISSK QKSVLPFFKM QKDNSFDLTL PSPSIQSTSQ
     KPQKDISFGF TLPSQSFPST SPGSNSENKE PLYKKLQMND RESFIIHSGN KTNVNDNKSC
     TGPAATTASG LNHTIKVSCP VCGTEVLECK INDHLDTCTS SGPQKDILLD VSLPLQSFPS
     TSQGSNSAIK EPLYKKLQIN DKDSFIIHSG NKTNVNDNKS CTRPAATTAS GFNHTIKVCC
     PVCGTDVLQD KINDHLDTCL QNCNT
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024